Inventor
BEARD JAMES DAVID
US14 patents
⚠️ This page may combine multiple inventors who share the name “BEARD JAMES DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTRA CELLULAR THERAPIES INC
7 patentsUS9751883B2Sep 5, 2017
Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC86 citations99
US9315504B2Apr 19, 2016
Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof
INTRA CELLULAR THERAPIES INC88 citations99
US10464938B2Nov 5, 2019
Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC33 citations98
US10221176B2Mar 5, 2019
Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC28 citations98
US11066407B2Jul 20, 2021
Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC14 citations94
US10597395B2Mar 24, 2020
Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereof
INTRA CELLULAR THERAPIES INC23 citations94
US12139490B2Nov 12, 2024
Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one
INTRA CELLULAR THERAPIES INC0 citations62